Outcome of Infusional 5-Fluorouracil, Doxorubicin, and Mitomycin-C (iFAM) Chemotherapy and Analysis of Prognostic Factors in Patients with Refractory Advanced Biliary Tract Cancer
Oncology, 06/29/2012
Clinical Article
Lim KH et al. – Infusional 5–fluorouracil (5–FU), doxorubicin, and mitomycin–C (iFAM) as salvage regimen has modest effect and tolerable toxicity in advanced biliary tract cancer (BTC). The described risk group classification may help guide treatment plans.



